From CancerNetwork: “Men with metastatic castrate resistant prostate cancer (mCRPC) with undetectable circulating tumor counts (CTCs) were 6.1-fold more likely to have complete response to…
Category: S1216
“Amir Goldkorn, MD, of USC Norris Comprehensive Cancer Center, discusses findings from SWOG S1216, which showed that using circulating tumor cell (CTC) count at…
Watch it here: New biomarker may guide initial treatment of metastatic prostate cancer – Keck Medicine of USC (broadcastmed.net) “Prostate cancer is the most common…